The biologics listed below were the 20 largest selling biologic drugs in 2006, accounting for $49.4 billion in sales worldwide. This represented about three quarters of the $64+ billion in sales of biologic therapeutic proteins and therapeutic antibodies.
| 2006 |
Name of Biologic |
2005 |
Use |
1 |
Enbrel |
1 |
Treating rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and psoriasis |
2 |
Aranesp |
3 |
Treating anemia in kidney and cancer patients |
3 |
Rituxan |
4 |
Treating non-Hodgkin's lymphoma and rheumatoid arthritis |
4 |
Remicade |
5 |
Treating rheumatoid arthritis and psoriasis |
5 |
Procrit |
2 |
Treating anemia in kidney and cancer patients |
6 |
Herceptin |
9 |
Treating metastatic breast cancer |
7 |
Epogen |
6 |
Treating anemia in kidney and cancer patients |
8 |
Neulasta |
7 |
Treating neutropenia (low level of white blood cells that help fight bacterial infections) |
9 |
Novolin |
|
Treating diabetes |
10 |
Avastin |
13 |
Treating metastatic colorectal cancer |
11 |
Lantus |
11 |
Treating diabetes |
12 |
Humira |
12 |
Treating rheumatoid arthritis and psoriasis |
13 |
Levemir |
|
Treating diabetes |
14 |
NeoRecormon |
8 |
Treating anemia in kidney and cancer patients |
15 |
Avonex |
10 |
Treating multiple sclerosis |
16 |
Rebif |
14 |
Treating multiple sclerosis |
17 |
Neupogen |
15 |
Treating neutropenia (low level of white blood cells that help fight bacterial infections) |
18 |
Humalog |
16 |
Treating diabetes |
19 |
Betaseron |
20 |
Treating multiple sclerosis |
20 |
Pegasys |
18 |
Treating hepatitis B and hepatitis C |
Rankings based on information reported by La Merie Business Intelligence |